Skip to main content
Erschienen in: Clinical Rheumatology 2/2021

14.07.2020 | Original Article

Cardiac valvular involvement of Takayasu arteritis

verfasst von: Yanlong Ren, Juan Du, Xi Guo, Ou Liu, Wenxian Liu, Guanming Qi, Lili Pan

Erschienen in: Clinical Rheumatology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aimed to investigate the imaging and serological features in Takayasu arteritis (TA) patients with valvular involvement and determine the relationship between them.

Method

This is a retrospective single-center study enrolled 103 TA patients fulfilling the American College of Rheumatology criteria. An independent medical chart review was performed by two senior rheumatologists from Beijing Anzhen Hospital, Capital Medical University. The logistic analysis was used to investigate the relationship between valvular involvement in TA patients and the imaging and serological features of them.

Results

Sixty-six TA patients (64.08%) had cardiac valvular involvement in our study. Aortic insufficiency (62.12%) was the most common valvular involvement. Twelve (22.22%) patients developed heart failure. In patients with valvular involvement, the most common angiographic type was Numano type V, which was significantly higher than that in patients without valvular involvement (53.30% vs 32.43%, p = 0.044), followed by coronary involvement (28.79% vs 10.81%, p = 0.036) and Numano type IIb (21.21% vs 5.41%, p = 0.034). Serum levels of immunoglobulin A (2.84 ± 1.42 g/L vs 2.26 ± 0.97 g/L, p = 0.032) and immunoglobulin G (13.5 ± 4.71 g/L vs 11.42 ± 3.01 g/L, p = 0.015) were significantly higher in patients with valvular involvement. Numano type IIb is significantly related to moderate-severe aortic valvular regurgitation in TA patients (4.10 [1.03–16.33], p = 0.04). Elevated C-reactive protein (CRP) level is associated with moderate-severe mitral valve involvement in TA patients (p = 0.05, OR = 17.75, 95% CI 1.07–295.41).

Conclusions

CRP elevation and Numano type IIb are significantly related to different types of valvular involvement in TA patients.
Key Points
• The Numano types IIb and V were common in TA patients with valvular involvement.
• CRP elevation and Numano type IIb are close related to valvular involvement in TA patient.
• Echocardiogram screening and CRP level examination are reasonable to TA patients which might have valvular involvement.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kim E, Beckman J (2017) Takayasu arteritis: challenges in diagnosis and management [J]. Heart Kim E, Beckman J (2017) Takayasu arteritis: challenges in diagnosis and management [J]. Heart
2.
Zurück zum Zitat Arnaud L, Haroche J, Mathian A et al (2011) Pathogenesis of Takayasu’s arteritis: a 2011 update [J]. Autoimmun Rev 11(1):61–67CrossRef Arnaud L, Haroche J, Mathian A et al (2011) Pathogenesis of Takayasu’s arteritis: a 2011 update [J]. Autoimmun Rev 11(1):61–67CrossRef
3.
Zurück zum Zitat Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis [J]. Ann Intern Med 120(11):919–929CrossRef Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis [J]. Ann Intern Med 120(11):919–929CrossRef
4.
Zurück zum Zitat Tombetti E, Mason JC (2018) Takayasu arteritis: advanced understanding is leading to new horizons [J]. Rheumatology (Oxford) Tombetti E, Mason JC (2018) Takayasu arteritis: advanced understanding is leading to new horizons [J]. Rheumatology (Oxford)
5.
Zurück zum Zitat Linnemeier L, Sharma R, Srivastava N et al (2017) Annuloplasty for aortic regurgitation in infantile Takayasu arteritis: a case report [J]. World J Pediatr Congenit Heart Surg 1474871347 Linnemeier L, Sharma R, Srivastava N et al (2017) Annuloplasty for aortic regurgitation in infantile Takayasu arteritis: a case report [J]. World J Pediatr Congenit Heart Surg 1474871347
6.
Zurück zum Zitat Slobodin G, Naschitz JE, Zuckerman E, Zisman D, Rozenbaum M, Boulman N, Rosner I (2006) Aortic involvement in rheumatic diseases [J]. Clin Exp Rheumatol 24(2 Suppl 41):S41–S47PubMed Slobodin G, Naschitz JE, Zuckerman E, Zisman D, Rozenbaum M, Boulman N, Rosner I (2006) Aortic involvement in rheumatic diseases [J]. Clin Exp Rheumatol 24(2 Suppl 41):S41–S47PubMed
7.
Zurück zum Zitat Mwipatayi BP, Jeffery PC, Beningfield SJ et al (2005) Takayasu arteritis: clinical features and management: report of 272 cases [J]. ANZ J Surg 75(3):110–117CrossRef Mwipatayi BP, Jeffery PC, Beningfield SJ et al (2005) Takayasu arteritis: clinical features and management: report of 272 cases [J]. ANZ J Surg 75(3):110–117CrossRef
8.
Zurück zum Zitat Li J, Li H, Sun F et al (2017) Clinical characteristics of heart involvement in Chinese patients with Takayasu arteritis [J]. J Rheumatol 44(12):1867–1874CrossRef Li J, Li H, Sun F et al (2017) Clinical characteristics of heart involvement in Chinese patients with Takayasu arteritis [J]. J Rheumatol 44(12):1867–1874CrossRef
9.
Zurück zum Zitat Zheng T, Zhu S, Ou JF et al (2018) Treatment with corticosteroid and/or immunosuppressive agents before surgery can effectively improve the surgical outcome in patients with Takayasu’s arteritis [J]. J Investig Surg:1–8 Zheng T, Zhu S, Ou JF et al (2018) Treatment with corticosteroid and/or immunosuppressive agents before surgery can effectively improve the surgical outcome in patients with Takayasu’s arteritis [J]. J Investig Surg:1–8
10.
Zurück zum Zitat An X, Han Y, Zhang B, Qiao L, Zhao Y, Guo X, Fang L, Zhu W, Fang Q, Shen Z, Zhang S (2017) Takayasu arteritis presented with acute heart failure: case report and review of literature [J]. ESC Heart Fail 4(4):649–654CrossRef An X, Han Y, Zhang B, Qiao L, Zhao Y, Guo X, Fang L, Zhu W, Fang Q, Shen Z, Zhang S (2017) Takayasu arteritis presented with acute heart failure: case report and review of literature [J]. ESC Heart Fail 4(4):649–654CrossRef
11.
Zurück zum Zitat Li J, Zhu M, Li M et al (2016) Cause of death in Chinese Takayasu arteritis patients [J]. Medicine (Baltimore) 95(27):e4069CrossRef Li J, Zhu M, Li M et al (2016) Cause of death in Chinese Takayasu arteritis patients [J]. Medicine (Baltimore) 95(27):e4069CrossRef
12.
Zurück zum Zitat Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis [J]. Arthritis Rheum 33(8):1129–1134CrossRef Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis [J]. Arthritis Rheum 33(8):1129–1134CrossRef
13.
Zurück zum Zitat Hata A, Noda M, Moriwaki R et al (1996) Angiographic findings of Takayasu arteritis: new classification [J]. Int J Cardiol 54(Suppl):S155–S163CrossRef Hata A, Noda M, Moriwaki R et al (1996) Angiographic findings of Takayasu arteritis: new classification [J]. Int J Cardiol 54(Suppl):S155–S163CrossRef
14.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO et al (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines [J]. J Am Coll Cardiol 70(2):252–289CrossRef Nishimura RA, Otto CM, Bonow RO et al (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines [J]. J Am Coll Cardiol 70(2):252–289CrossRef
15.
Zurück zum Zitat Misra R, Danda D, Sivakumar R et al. ITAS: the Indian Takayasu Activity Score for Takayasu arteritis [M]2009:85 Misra R, Danda D, Sivakumar R et al. ITAS: the Indian Takayasu Activity Score for Takayasu arteritis [M]2009:85
16.
Zurück zum Zitat Misra R, Misra D, Danda D et al. ITAS.A suggests persistent disease activity in Takayasu aorto-arteritis (TA) after induction therapy [M]2013:729–730 Misra R, Misra D, Danda D et al. ITAS.A suggests persistent disease activity in Takayasu aorto-arteritis (TA) after induction therapy [M]2013:729–730
17.
Zurück zum Zitat Yang L, Zhang H, Jiang X et al (2014) Clinical manifestations and long term outcome for patients with Takayasu arteritis in China [J]. J Rheumatol 41(12):2439–2446CrossRef Yang L, Zhang H, Jiang X et al (2014) Clinical manifestations and long term outcome for patients with Takayasu arteritis in China [J]. J Rheumatol 41(12):2439–2446CrossRef
18.
Zurück zum Zitat Soto ME, Espinola-Zavaleta N, Ramirez-Quito O, Reyes PA (2006) Echocardiographic follow-up of patients with Takayasu’s arteritis: five-year survival [J]. Echocardiography 23(5):353–360CrossRef Soto ME, Espinola-Zavaleta N, Ramirez-Quito O, Reyes PA (2006) Echocardiographic follow-up of patients with Takayasu’s arteritis: five-year survival [J]. Echocardiography 23(5):353–360CrossRef
19.
Zurück zum Zitat Wang H, Li L, Wang L, Chang Q, Pu J (2012) Comparison of clinical and pathological characteristics of isolated aortitis and Takayasu arteritis with ascending aorta involvement [J]. J Clin Pathol 65(4):362–366CrossRef Wang H, Li L, Wang L, Chang Q, Pu J (2012) Comparison of clinical and pathological characteristics of isolated aortitis and Takayasu arteritis with ascending aorta involvement [J]. J Clin Pathol 65(4):362–366CrossRef
20.
Zurück zum Zitat Kaku Y, Aomi S, Tomioka H, Yamazaki K (2015) Surgery for aortic regurgitation and aortic root dilatation in Takayasu arteritis [J]. Asian Cardiovasc Thorac Ann 23(8):901–906CrossRef Kaku Y, Aomi S, Tomioka H, Yamazaki K (2015) Surgery for aortic regurgitation and aortic root dilatation in Takayasu arteritis [J]. Asian Cardiovasc Thorac Ann 23(8):901–906CrossRef
21.
Zurück zum Zitat Adachi O, Saiki Y, Akasaka J, Oda K, Iguchi A, Tabayashi K (2007) Surgical management of aortic regurgitation associated with takayasu arteritis and other forms of aortitis [J]. Ann Thorac Surg 84(6):1950–1953CrossRef Adachi O, Saiki Y, Akasaka J, Oda K, Iguchi A, Tabayashi K (2007) Surgical management of aortic regurgitation associated with takayasu arteritis and other forms of aortitis [J]. Ann Thorac Surg 84(6):1950–1953CrossRef
22.
Zurück zum Zitat Matsuura K, Ogino H, Kobayashi J et al (2005) Surgical treatment of aortic regurgitation due to Takayasu arteritis: long-term morbidity and mortality [J]. Circulation 112(24):3707–3712CrossRef Matsuura K, Ogino H, Kobayashi J et al (2005) Surgical treatment of aortic regurgitation due to Takayasu arteritis: long-term morbidity and mortality [J]. Circulation 112(24):3707–3712CrossRef
23.
Zurück zum Zitat Ando M, Kosakai Y, Okita Y et al (1998) Surgical treatment for aortic regurgitation caused by Takayasu’s arteritis [J]. J Card Surg 13(3):202–207CrossRef Ando M, Kosakai Y, Okita Y et al (1998) Surgical treatment for aortic regurgitation caused by Takayasu’s arteritis [J]. J Card Surg 13(3):202–207CrossRef
24.
Zurück zum Zitat Fujiwara K, Hamuro M, Imai K, Yoshizawa K, Ohno N, Sakazaki H, Tsukuda K (2013) Severe aortic valve regurgitation due to Takayasu’s aortoarteritis in a child [J]. Ann Thorac Surg 96(3):1072–1074CrossRef Fujiwara K, Hamuro M, Imai K, Yoshizawa K, Ohno N, Sakazaki H, Tsukuda K (2013) Severe aortic valve regurgitation due to Takayasu’s aortoarteritis in a child [J]. Ann Thorac Surg 96(3):1072–1074CrossRef
25.
Zurück zum Zitat Kato Y, Terashima M, Ohigashi H et al (2015) Vessel Wall inflammation of Takayasu arteritis detected by contrast-enhanced magnetic resonance imaging: association with disease distribution and activity [J]. PLoS One 10(12):e145855 Kato Y, Terashima M, Ohigashi H et al (2015) Vessel Wall inflammation of Takayasu arteritis detected by contrast-enhanced magnetic resonance imaging: association with disease distribution and activity [J]. PLoS One 10(12):e145855
26.
Zurück zum Zitat Comarmond C, Biard L, Lambert M et al (2017) Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients [J]. Circulation 136(12):1114–1122CrossRef Comarmond C, Biard L, Lambert M et al (2017) Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients [J]. Circulation 136(12):1114–1122CrossRef
27.
Zurück zum Zitat Blank M, Krause I, Goldkorn T, Praprotnik S, Livneh A, Langevitz P, Kaganovsky E, Morgenstern S, Cohen S, Barak V, Eldor A, Weksler B, Shoenfeld Y (1999) Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels [J]. Arthritis Rheum 42(7):1421–1432CrossRef Blank M, Krause I, Goldkorn T, Praprotnik S, Livneh A, Langevitz P, Kaganovsky E, Morgenstern S, Cohen S, Barak V, Eldor A, Weksler B, Shoenfeld Y (1999) Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels [J]. Arthritis Rheum 42(7):1421–1432CrossRef
28.
Zurück zum Zitat Hadjadj J, Canaud G, Mirault T et al (2018) mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G [J]. Rheumatology (Oxford) Hadjadj J, Canaud G, Mirault T et al (2018) mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G [J]. Rheumatology (Oxford)
Metadaten
Titel
Cardiac valvular involvement of Takayasu arteritis
verfasst von
Yanlong Ren
Juan Du
Xi Guo
Ou Liu
Wenxian Liu
Guanming Qi
Lili Pan
Publikationsdatum
14.07.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 2/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05290-2

Weitere Artikel der Ausgabe 2/2021

Clinical Rheumatology 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.